Jingye Zhou, Eccogene CEO Eccogene files for Hong Kong IPO to back development of GLP-1 pipeline Eccogene, a clinical-stage biotech whose oral GLP-1 drug forms the backbone of AstraZenecas obesity pipeline, is planning an initial public offering on the Hong Kong Sign up to read this article for free
EMBO J 20:66276636
doi: 10.1038/s41579-019-0213-6 133 SchneiderH.BlautM
Trending brands like Dedcool and Sol de Janeiro underscore the impact of distinctive scents with less traditional product formats, such as mists, creams and even laundry detergent
They need steady blood sugar control over time
LIABILITY: SJ Pep shall not be held liable for any damages consequential, incidental, or otherwise arising from the purchase, use, or misuse of these products